← brief for 2026-09-06 · Slowing decline

[Treatment of Hypercholesterolemia in Chronic Kidney Disease: Rationale and Therapeutic Approaches from the Non-Dialysis Stage to Kidney Transplantation].

Key takeaways

Most people with kidney disease face heart attacks and strokes, often before their kidneys fail. This review walks through how LDL cholesterol, the harmful kind, drives that risk at every stage, from early kidney disease through dialysis and transplant, and what the older and newer cholesterol drugs do at each stage. It is a summary of existing guidance and evidence, not a new study, so it reports no new results.

Who did this work

Minutolo R · Ravera M · Cozzolino M · Di Lullo L · Paoletti E · De Nicola L

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 31
https://pubmed.ncbi.nlm.nih.gov/42701858/